Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value.

Tice, Jeffrey A, Dhruv S Kazi, and Steven D Pearson. 2016. “Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value.”. JAMA Internal Medicine 176 (1): 107-8.

Publisher's Version

Last updated on 09/26/2024
PubMed